We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-6.01%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.76B
AUM Growth
-$145M
Cap. Flow
-$6.24M
Cap. Flow %
-0.35%
Top 10 Hldgs %
63.59%
Holding
49
New
2
Increased
19
Reduced
18
Closed
3

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$75M
2
NVDA icon
NVIDIA
NVDA
+$41.2M
3
MSFT icon
Microsoft
MSFT
+$29.3M
4
PG icon
Procter & Gamble
PG
+$21.5M
5
V icon
Visa
V
+$14.4M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$67.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$28.1M
4
WMT icon
Walmart Inc
WMT
+$17.1M
5
RTX icon
RTX Corp
RTX
+$10.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.2%
2 Technology 19.18%
3 Communication Services 16.18%
4 Consumer Staples 13.12%
5 Industrials 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.2T
$176M 9.96%
610,629
-109,218
-15% -$34.3M
MSFT icon
2
Microsoft
MSFT
$3.66T
$137M 7.75%
368,821
+70,113
+23% +$29.3M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.09T
$130M 7.4%
272,031
+8,769
+3% +$4.3M
NVO
4
Novo Nordisk
NVO
$203B
$126M 7.17%
3,436,329
+1,583,763
+85% +$75M
DIS icon
5
Walt Disney
DIS
$178B
$109M 6.17%
1,128,428
+104,645
+10% +$11.1M
UL icon
6
Unilever
UL
$133B
$107M 6.06%
1,873,359
+20,264
+1% +$1.36M
MDT icon
7
Medtronic
MDT
$116B
$102M 5.78%
1,175,571
+20,425
+2% +$1.96M
ASML icon
8
ASML
ASML
$695B
$84.9M 4.82%
64,285
-5,951
-8% -$8.15M
JNJ icon
9
Johnson & Johnson
JNJ
$629B
$83M 4.71%
339,441
-120,782
-26% -$28.1M
GD icon
10
General Dynamics
GD
$107B
$66.7M 3.78%
194,242
+5,563
+3% +$1.97M
NVDA icon
11
NVIDIA
NVDA
$5.43T
$58.7M 3.33%
336,724
+224,441
+200% +$41.2M
SBUX icon
12
Starbucks
SBUX
$124B
$56.4M 3.2%
629,785
+36,319
+6% +$3.44M
PG icon
13
Procter & Gamble
PG
$335B
$52M 2.95%
360,225
+142,100
+65% +$21.5M
RTX icon
14
RTX Corp
RTX
$300B
$50M 2.84%
259,071
-53,932
-17% -$10.7M
V icon
15
Visa
V
$671B
$47.3M 2.68%
156,373
+44,676
+40% +$14.4M
LLY icon
16
Eli Lilly
LLY
$1.09T
$42.8M 2.43%
46,525
-1,630
-3% -$1.65M
CHRW icon
17
C.H. Robinson
CHRW
$17.1B
$41.8M 2.37%
251,844
-55,797
-18% -$9.98M
HON icon
18
Honeywell
HON
$74.6B
$37.5M 2.13%
165,945
+26,260
+19% +$6M
HD icon
19
Home Depot
HD
$342B
$29.2M 1.66%
88,808
-2,583
-3% -$941K
AAPL icon
20
Apple
AAPL
$4.41T
$28.4M 1.61%
111,983
-3,559
-3% -$926K
DEO icon
21
Diageo
DEO
$52.2B
$28.2M 1.6%
378,141
+107,083
+40% +$9.34M
PEP icon
22
PepsiCo
PEP
$189B
$26.9M 1.53%
173,317
+1,035
+0.6% +$161K
ACN icon
23
Accenture
ACN
$110B
$26.5M 1.5%
133,660
-1,924
-1% -$448K
BIL icon
24
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$19.7M 1.12%
215,077
-10,104
-4% -$925K
CL icon
25
Colgate-Palmolive
CL
$73.6B
$16.2M 0.92%
190,095
+3,532
+2% +$315K

Similar funds

Saratoga Research & Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Saratoga Research & Investment Management held 49 positions worth $1.76B, down 7.6% from $1.91B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Saratoga Research & Investment Management's Q1 2026 filing shows 2 new, 19 increased, 18 reduced and 3 closed positions. Its largest new stake was Vanguard Real Estate ETF: 5,414 shares worth $480K. The largest sale was Oracle, an estimated $67.4M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.

  • Saratoga Research & Investment Management's largest Q1 2026 buy was Vanguard Real Estate ETF: 5,414 shares worth $480K.
  • Saratoga Research & Investment Management added most to Novo Nordisk in Q1 2026, an estimated $75M increase.
  • Saratoga Research & Investment Management's biggest Q1 2026 reduction was Alphabet (Google) Class A, cutting an estimated $34.3M.
  • Saratoga Research & Investment Management fully exited Oracle in Q1 2026, selling an estimated $67.4M.
  • Saratoga Research & Investment Management's ten largest holdings make up 64% of its $1.76B portfolio in Q1 2026.
  • Saratoga Research & Investment Management opened 2 new positions and closed 3 in Q1 2026.
  • Saratoga Research & Investment Management's portfolio value fell 7.6% quarter-over-quarter to $1.76B.

Based on Saratoga Research & Investment Management's 13F filing for Q1 2026, filed 8 May 2026.